I just published an article on some promising breakthroughs in HIV prevention. Current prophylactics have to be taken once a day, and missing even a single dose means waning protection. But a new wave of long-acting preventatives that last for a month, two months, even half a year—and significantly reduce infections—is set to transform the fight against HIV/AIDS. That’s why we’re committed to making these tools affordable and accessible worldwide.